IdentifySensors Biologics develops a digital diagnostics platform built around semiconductor sensors printed with a proprietary graphene ink. The sensors are integrated into a multiplex test cartridge about the size of a cell phone and connect to a reusable Bluetooth reader that transmits data to a mobile app and cloud‑based algorithms to generate results in minutes. Each sensor can be programmed to detect and differentiate multiple pathogens or biomarkers from small (half‑milliliter) samples such as blood or saliva. The company has started manufacturing and plans its first FDA submission later this year. IdentifySensors holds over 20 patents on its technology and manufacturing processes. It has raised $20 million to commercialize the platform and is seeking an additional $7.5 million to scale production and develop more test targets, with a three‑year plan to expand rapid molecular tests to many common diseases and molecularly detectable cancers.

Total raised

$20M

Funding rounds

1

Latest round

Equity

Latest activity

Mar 2025